These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 15135087

  • 1. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
    Tang J, Amin Usmani K, Hodgson E, Rose RL.
    Chem Biol Interact; 2004 Apr 15; 147(3):319-29. PubMed ID: 15135087
    [Abstract] [Full Text] [Related]

  • 2. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
    Usmani KA, Hodgson E, Rose RL.
    Chem Biol Interact; 2004 Dec 07; 150(3):221-32. PubMed ID: 15560889
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ, Yokoyama H, Chiba K, Wanwimolruk S, Ishizaki T.
    J Pharmacol Exp Ther; 1996 Dec 07; 279(3):1327-34. PubMed ID: 8968357
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates.
    Zhao K, Ding M, Cao H, Cao ZX.
    J Pharm Pharmacol; 2012 Oct 07; 64(10):1445-51. PubMed ID: 22943175
    [Abstract] [Full Text] [Related]

  • 7. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT, Chang YW, Lan SJ, Yeh TK.
    Food Chem Toxicol; 2008 Feb 07; 46(2):645-53. PubMed ID: 17950511
    [Abstract] [Full Text] [Related]

  • 8. An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats.
    Mei L, Zhang L, Dai R.
    J Enzyme Inhib Med Chem; 2009 Jun 07; 24(3):753-62. PubMed ID: 18956271
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes.
    Kawashiro T, Yamashita K, Zhao XJ, Koyama E, Tani M, Chiba K, Ishizaki T.
    J Pharmacol Exp Ther; 1998 Sep 07; 286(3):1294-300. PubMed ID: 9732391
    [Abstract] [Full Text] [Related]

  • 11. Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4.
    Störmer E, von Moltke LL, Shader RI, Greenblatt DJ.
    Drug Metab Dispos; 2000 Oct 07; 28(10):1168-75. PubMed ID: 10997935
    [Abstract] [Full Text] [Related]

  • 12. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs.
    Li J, Liu Y, Zhang JW, Wei H, Yang L.
    Comp Med; 2006 Aug 07; 56(4):286-90. PubMed ID: 16941956
    [Abstract] [Full Text] [Related]

  • 13. Metabolic interactions of agrochemicals in humans.
    Hodgson E, Rose RL.
    Pest Manag Sci; 2008 Jun 07; 64(6):617-21. PubMed ID: 18322939
    [Abstract] [Full Text] [Related]

  • 14. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism.
    Mei Q, Tang C, Assang C, Lin Y, Slaughter D, Rodrigues AD, Baillie TA, Rushmore TH, Shou M.
    J Pharmacol Exp Ther; 1999 Nov 07; 291(2):749-59. PubMed ID: 10525096
    [Abstract] [Full Text] [Related]

  • 15. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
    Zhou S, Paxton JW, Tingle MD, Kestell P.
    Drug Metab Dispos; 2000 Dec 07; 28(12):1449-56. PubMed ID: 11095582
    [Abstract] [Full Text] [Related]

  • 16. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
    Kitamura A, Mizuno Y, Natsui K, Yabuki M, Komuro S, Kanamaru H.
    Biopharm Drug Dispos; 2005 Mar 07; 26(2):59-65. PubMed ID: 15619261
    [Abstract] [Full Text] [Related]

  • 17. Identification of human cytochrome P-450 isoforms involved in metabolism of R(+)- and S(-)-gallopamil: utility of in vitro disappearance rate.
    Suzuki A, Iida I, Tanaka F, Akimoto M, Fukushima K, Tani M, Ishizaki T, Chiba K.
    Drug Metab Dispos; 1999 Nov 07; 27(11):1254-9. PubMed ID: 10534309
    [Abstract] [Full Text] [Related]

  • 18. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS, Hatch HL, Kosea F, Nguyen HT, Choo EF, McClure KF, Taylor TJ, Henne KR, Kuperman AV, Dombroski MA, Letavic MA.
    Biopharm Drug Dispos; 2006 Nov 07; 27(8):371-86. PubMed ID: 16944451
    [Abstract] [Full Text] [Related]

  • 19. Development of a non-high pressure liquid chromatography assay to determine testosterone hydroxylase (CYP3A) activity in human liver microsomes.
    Draper AJ, Madan A, Smith K, Parkinson A.
    Drug Metab Dispos; 1998 Apr 07; 26(4):299-304. PubMed ID: 9531515
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.
    Nakajima M, Ohyama K, Nakamura S, Shimada N, Yamazaki H, Yokoi T.
    Drug Metab Dispos; 1999 Jul 07; 27(7):792-7. PubMed ID: 10383922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.